Innovation in European healthcare â what can Sweden learn? - LIF
Innovation in European healthcare â what can Sweden learn? - LIF
Innovation in European healthcare â what can Sweden learn? - LIF
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The reform is controversial – private <strong>healthcare</strong><br />
providers <strong>in</strong> the public system are not accepted <strong>in</strong> the<br />
same way as <strong>in</strong> Germany or France<br />
• The government aims to strengthen the voice of<br />
patients through the sett<strong>in</strong>g up of a new national<br />
body, HealthWatch, and local HealthWatch<br />
organisations.<br />
• A new body, Public Health England, will lead<br />
on public health at the national level, and local<br />
authorities will do so at a local level<br />
• Key regulators – CQC and NICE– will be<br />
reta<strong>in</strong>ed, though it rema<strong>in</strong>s to be seen how their<br />
roles may change.<br />
• A new regulator, Monitor, will be established to<br />
regulate providers of NHS services <strong>in</strong> the<br />
<strong>in</strong>terests of patients and prevent anticompetitive<br />
behaviour<br />
• In addition, it is already clear that the new<br />
government <strong>in</strong>tends to restrict NHS<br />
expenditure compared with previous regimes.<br />
This is almost certa<strong>in</strong> to have an impact on the<br />
delivery of NHS services.<br />
• Accord<strong>in</strong>g to many commentators, the recent<br />
Spend<strong>in</strong>g Review plans for the NHS (October<br />
2011) amount to a de facto cut <strong>in</strong> NHS<br />
spend<strong>in</strong>g <strong>in</strong> real terms.<br />
• For example the British Medical Association<br />
rema<strong>in</strong>s <strong>in</strong> “outright opposition” to the reform.<br />
• One of the most persistent criticisms of the<br />
reforms has been that this could amount to<br />
partial privatisation of the NHS. Critics fear a<br />
“rush to the bottom”, as providers may slash<br />
costs to w<strong>in</strong> contracts, driv<strong>in</strong>g down quality of<br />
treatment for patients.<br />
• Another major concern is about fragmentation of<br />
the NHS and a loss of coord<strong>in</strong>ation and plann<strong>in</strong>g<br />
as a result of the abolishment of PCT’s.<br />
• The Lancet predicted an "unprecedented chaos"<br />
as a result of the reforms, with a leaked draft<br />
risk-assessment show<strong>in</strong>g that emergencies<br />
would be less well managed and the <strong>in</strong>creased<br />
use of the private sector would drive up costs.<br />
• The health th<strong>in</strong>k tank “The K<strong>in</strong>g's Fund” state<br />
that private sector organisations have always<br />
played an important role <strong>in</strong> the NHS and that<br />
"the NHS will rema<strong>in</strong> a publicly funded system<br />
under the proposals, and at least for the<br />
foreseeable future the majority of services are<br />
likely to be provided by NHS organisations".<br />
140